Cell therapy downstream processing and analytics

CELL AND GENE THERAPY INSIGHTS

November 2024

Cell therapy downstream processing and analytics

Expert Insight

Interpreting the new FDA draft potency guidance: an RNA cell therapy perspective

Interpreting the new FDA draft potency guidance: an RNA cell therapy perspective

Damian Marshall, Kayleigh Thirlwell

2 December 2024

Review

Phase-appropriate analytical control of cell therapy manufacture in early development stages

Phase-appropriate analytical control of cell therapy manufacture in early development stages

11 November 2024

FastFacts

Novel isolation platform with active-release technology for scalable cell therapy manufacturing

Novel isolation platform with active-release technology for scalable cell therapy manufacturing

Ingrid Nyhus Moen

18 December 2024

EBook

eBook: Increasing speed and efficiency in biotherapeutics analysis

eBook: Increasing speed and efficiency in biotherapeutics analysis

Infographic

Manufacturing of CD19 CAR-T cells: INFOGRAPHIC

Manufacturing of CD19 CAR-T cells: INFOGRAPHIC

19 December 2024

Cell therapy analytics: INFOGRAPHIC

Cell therapy analytics: INFOGRAPHIC

22 November 2024

Interview

Pioneering quality control in biomanufacturing of cell and gene therapies

Pioneering quality control in biomanufacturing of cell and gene therapies

Dhruv Sareen, Jonathan Rodriguez

5 December 2024

Troubleshooting process and analytical tool changes in an approved ATMP process

Troubleshooting process and analytical tool changes in an approved ATMP process

Maitane Ortiz, Marta Malo De Molina

3 December 2024

Exploring innovations in CAR-T therapy for solid tumors: the role of automated systems, analytical testing, and AI

Exploring innovations in CAR-T therapy for solid tumors: the role of automated systems, analytical testing, and AI

Webinars

Enhancing CAR-T therapy development: harnessing cell selection flexibility

Enhancing CAR-T therapy development: harnessing cell selection flexibility

Tamara Laskowski, Nuala Trainor

Optimizing for the future: streamlining the production of T cell-based immunotherapies

Optimizing for the future: streamlining the production of T cell-based immunotherapies

Paula Lam, Soong Poh Loong

30 October 2024